← All stocks

Monte Rosa Therapeutics, Inc.

GLUE No buying or selling

CIK 0001826457 #2381 in the set updated 19 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

11 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Versant Venture Capital VI, L.P. entity

10% owner

—

5,652,922

$131.04M

−32.1%

Warmuth Markus

President & CEO

—

585,038

$13.56M

+40.5%

Townson Sharon

Chief Scientific Officer

—

67,845

$1.57M

—

Champoux Jennifer

Chief Operating Officer

—

62,371

$1.45M

—

Janku Filip

Chief Medical Officer

—

60,612

$1.41M

+413.6%

Nickson Philip

Chief Business & Legal Officer

—

55,000

$1.27M

—

Bowen Matthew

Principal Accounting Officer

—

25,904

$600.48K

+19.9%

Dunn Edmund

Principal Accounting Officer

—

22,554

$522.82K

+61.7%

Leo Chandra P.

Director

—

10,000

$231.81K

—

Behbahani Ali

Director

—

$0.00

−100.0%

Manning Anthony M.

Director

—

$0.00

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 25 Jun 2021